In the era of immune checkpoints inhibition for cancer clinical management, the role of programmed death-1 (PD-1) expressed by T cells and its ligand programmed death-ligand 1 (PD-L1) expressed by cancer cells and anti-inflammatory cells have been investigated also in GBC. This evidence concerns the gene CD274 and cancer.